Predictive and prognostic significance of BRCAness in HER2-negative breast cancer.

Aiko SuetaMutsuko Yamamoto-IbusukiMai TomiguchiYoshitaka FujikiLisa Goto-YamaguchiHirotaka IwaseYutaka Yamamoto

Published in: Breast cancer (Tokyo, Japan) (2022)

BRCAness may be useful biomarkers to predict prognosis for HER2-negative breast cancer refractory to standard chemotherapy. Our results pave the way for identifying patients who require alternative therapies.

Keyphrases

locally advanced
squamous cell carcinoma
radiation therapy
breast cancer risk
rectal cancer